glp-1 obesity drug news today september 29 2025 New Daily Weight Loss Pill Aims to Take on Ozempic Weight-loss drug makers announce pricing

Successful pharmacological management usually starts with a good relationship between the healthcare professional and the patient

Less Frequent Dosing# Weekly injections require dosing just 52 times per year, versus 365 times for daily oral pills

However, whereas the majority of hepatotoxic compounds cause centrilobular injury, some xenobiotics, such as allyl formage, elemental phosphorus, and allyl alcohol, preferentially damage periportal hepatocytes, presumably as a result of rapid first-pass uptake by these upstream hepatocytes

The National Active and Retired Federal Employees Association (NARFE) has highlighted the Medicare GLP-1 Bridge as an important development for many federal retirees who previously found GLP-1 medications difficult to afford

With the fresh clinical data at their disposal, the drugs sponsor can start filing for marketing authorization